Skip to Content
Opening Bell
News
BenzingaOctober 5, 2026 at 12:56 PM NY22 Days Ago

UBS Maintains Neutral on CME Group, Raises Price Target to $270

UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga

Read at Source